01184nam a2200301Ia 4500001001200000003000800012006001900020007001500039008004100054020001800095020001800113040002100131035002100152050002400173245009700197260005800294300002300352490004300375504005100418533015200469650002200621650002700643655002900670700002100699710001700720856012600737999001900863ebr10188620CaPaEBRm        u        cr cn|||||||||930716s2007    ctua    sb    001 0 eng d  z9780444521736  z9780080548241  aCaPaEBRcCaPaEBR  a(OCoLC)64831644414aRM411b.A383 2007eb00aAdvances in antiviral drug design.nVolume 5h[electronic resource] /ceditor, E. De Clercq.  aGreenwich, CT ;aLondon, England :bJai Press,c2007.  axi, 251 p. :bill.0 aAdvances in antiviral drug design ;v5  aIncludes bibliographical references and index.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2013.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aAntiviral agents. 0aAnti-infective agents. 7aElectronic books.2local1 aDe Clercq, Erik.2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10188620zAn electronic book accessible through the World Wide Web; click to view  c149036d149036